Clari Vest Asset Management LLC Kura Oncology, Inc. Transaction History

Clari Vest Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$15.42 - $21.72 $384,698 - $541,870	-24,948 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$20.85 - $29.88 $1,251 - $1,792	60 Added 0.24%	24,948 $520,000
Q1 2021 May 13, 2021	SELL	$24.75 - $39.14 $368,775 - $583,186	-14,900 Reduced 37.45%	24,888 $704,000
Q4 2020 Feb 09, 2021	SELL	$29.0 - $41.62 $1.12 Million - $1.61 Million	-38,598 Reduced 49.24%	39,788 $1.3 Million
Q3 2020 Nov 09, 2020	SELL	$16.3 - $30.64 $61,076 - $114,808	-3,747 Reduced 4.56%	78,386 $2.4 Million
Q2 2020 Aug 12, 2020	SELL	$7.95 - $18.81 $169,660 - $401,424	-21,341 Reduced 20.62%	82,133 $1.34 Million
Q1 2020 May 04, 2020	BUY	$6.45 - $14.04 $37,687 - $82,035	5,843 Added 5.98%	103,474 $1.03 Million
Q4 2019 Feb 12, 2020	SELL	$12.97 - $15.94 $588,085 - $722,751	-45,342 Reduced 31.71%	97,631 $1.34 Million
Q3 2019 Nov 12, 2019	BUY	$14.75 - $20.87 $1.72 Million - $2.43 Million	116,273 Added 435.48%	142,973 $2.17 Million
Q2 2019 Aug 16, 2019	BUY	$14.71 - $19.79 $392,757 - $528,393	26,700 New	26,700 $526,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.